ArticleJournal of experimental & clinical cancer research : CR2018

Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma.

Cheng-Lung Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.